These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17279108)

  • 41. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance.
    Prosser JM; Steinfeld M; Cohen LJ; Derbyshire S; Eisenberg DP; Cruciani RA; Galynker II
    Drug Alcohol Depend; 2008 Jun; 95(3):237-44. PubMed ID: 18353568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prescription shopping of addictive drugs in Norway].
    Winther RB; Bramness JG
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F; Manzato E; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain.
    Romo N; Poo M; Ballesta R;
    Drug Alcohol Rev; 2009 Mar; 28(2):186-95. PubMed ID: 19320704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism.
    McMillan GP; Lapham S; Lackey M
    Addiction; 2008 Dec; 103(12):2017-23. PubMed ID: 19469745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?
    Gerra G; Maremmani I; Capovani B; Somaini L; Berterame S; Tomas-Rossello J; Saenz E; Busse A; Kleber H
    Subst Use Misuse; 2009; 44(5):663-71. PubMed ID: 19360539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of heroin addiction--clinical findings hand-in-hand with evidence].
    Berglund M; Jonsson E; Thelander S
    Lakartidningen; 2001 Oct; 98(41):4487. PubMed ID: 11699259
    [No Abstract]   [Full Text] [Related]  

  • 53. The trouble with morality: the effects of 12-step discourse on addicts' decision-making.
    Frank D
    J Psychoactive Drugs; 2011; 43(3):245-56. PubMed ID: 22111408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of pilot methadone maintenance therapy in Georgia (Caucasus).
    Gambashidze N; Sikharulidze Z; Piralishvili G; Gvakharia N
    Georgian Med News; 2008; (160-161):25-30. PubMed ID: 18711233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Weight gain among the patients in methadone maintenance program as come-back to population norm].
    Okruhlica L; Slezáková S
    Cas Lek Cesk; 2008; 147(8):426-30. PubMed ID: 18777802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proportional hazards frailty models for recurrent methadone maintenance treatment.
    Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
    Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of acute pain in methadone maintenance therapy in-patients.
    Hines S; Theodorou S; Williamson A; Fong D; Curry K
    Drug Alcohol Rev; 2008 Sep; 27(5):519-23. PubMed ID: 18696299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.